Elanco Animal Health ELAN
NYSE ELAN
$23.76 -0.74 (-3.00%)
At close: Aug 20, 2026 · 12:51 PM UTC

Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2026)

Elanco Animal Health (ELAN) posted Other Non-Current Liabilities of $467.0 million for Q1 2026, up 53.62% sequentially from $304.0 million in Q4 2025, and down 4.11% YoY from $487.0 million in Q1 2025.

Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

Elanco Animal Health has reported Other Non-Current Liabilities for 10 years, with the latest figure at $467.0 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 4.11% year-over-year to $467.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $467.0 million (down 4.11% YoY) and the FY2025 annual result came in at $304.0 million, up 0.66% from the prior year.
  • Other Non-Current Liabilities advanced to $467.0 million in Q1 2026 per ELAN's latest filing, from $304.0 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $638.0 million in Q2 2025 and troughed at $225.0 million in Q3 2022.
  • A 5-year average of $398.1 million and a median of $411.0 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • The widest YoY moves for Other Non-Current Liabilities: up 93.47% in 2024, down 26.52% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $229.0 million in 2022, then surged by 79.48% to $411.0 million in 2023, then declined by 26.52% to $302.0 million in 2024, then rose by 0.66% to $304.0 million in 2025, then soared by 53.62% to $467.0 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $467.0 million, $304.0 million, and $607.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 551.00 Mn
Mar 31, 2026 467.00 Mn
Dec 31, 2025 304.00 Mn
Sep 30, 2025 607.00 Mn
Jun 30, 2025 638.00 Mn
Mar 31, 2025 487.00 Mn
Dec 31, 2024 302.00 Mn
Sep 30, 2024 587.00 Mn
Jun 30, 2024 465.00 Mn
Mar 31, 2024 474.00 Mn
Dec 31, 2023 411.00 Mn
Sep 30, 2023 432.00 Mn
Jun 30, 2023 411.00 Mn
Mar 31, 2023 245.00 Mn
Dec 31, 2022 229.00 Mn
Sep 30, 2022 225.00 Mn
Jun 30, 2022 242.00 Mn
Mar 31, 2022 242.00 Mn
Dec 31, 2021 262.00 Mn
Sep 30, 2021 220.00 Mn